Symposium perspective.
D000583:Amikacin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives
D007612:Kanamycin; D000583:Amikacin